ProQuest Associates IV LLC, 10% Owner at EAGLE PHARMACEUTICALS, INC. (EGRX), sold 155,800 shares at $70.04 ($10.9M) on 2016-09-29, disclosed to the SEC on 2016-09-30.
Open-market sale of $10.9M EGRX by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $70.04 | 77,900 | $5.5M | 50.0% |
| 2 | $70.04 | 77,900 | $5.5M | 50.0% |
| Total | $70.04 avg | 155,800 | $10.9M | 100% |
| Filing → |
| EGRX | SELL | 2017-01-06 | $11.1M | — | Filing → |
| EGRX | SELL | 2016-11-14 | $4.2M | — | Filing → |
| EGRX | SELL | 2016-11-04 | $21.0M | — | Filing → |